Home
Conditions
Parkinsonian Disorders

Clinical trial condition

Parkinsonian Disorders

Explore clinical trials studying Parkinsonian Disorders. Study availability and eligibility vary by location and protocol.

3,327 public trials 611 recruiting studies

Refine in advanced search Browse all conditions

Parkinsonian Disorders trial results

Completed

Continued Efficacy and Safety of Apomorphine in Patients With Late-Stage Parkinsons Disease

NCT00200525

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations: Not specified

View Trial Details

Completed

Continued Efficacy of Apomorphine After Previous Exposure of at Least Three Months

NCT00200512

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations: Walton Centre for Neurology and Neurosurgery Liverpool, United Kingdom

The Morriston Hospital Swansea, United Kingdom

View Trial Details

Completed

Safety and Efficacy of Galantamine in Patients With Dementia With Lewy Bodies

NCT00230997

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +9 more
Locations: Indiana University for AD and Related Disorders Indianapolis, Indiana, United States

Buffalo Insititute for Medical Research Buffalo, New York, United States

Alzheimer's Center of Pittsburgh Pittsburgh, Pennsylvania, United States

UTHSCSA Psychiatry Department San Antonio, Texas, United States

View Trial Details

Completed

Treatment of Hallucinosis/Psychosis in Parkinson's Disease by an Investigational Drug

NCT00087542

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +17 more
Locations: Fountain Valley, California, United States

Sunnyvale, California, United States

Danbury, Connecticut, United States

Pompano Beach, Florida, United States

View all 13 locations

View Trial Details

Completed

Randomized Study of the Effects of Glucose on Cognition in Healthy Young and Elderly People and Parkinson's Disease Patients

NCT00004451

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +13 more
Locations: University of Virginia Charlottesville, Virginia, United States

View Trial Details

Completed

Efficacy of Therapeutic Interventions for Orthostatic Hypotension in Parkinson's Disease and Multiple System Atrophy

NCT00103597

Conditions: Autonomic Nervous System Diseases, Basal Ganglia Diseases, Brain Diseases, +16 more
Locations: Royal Brisbane and Women's Hospital Brisbane, Queensland, Australia

View Trial Details

Completed

A Sub-Study With Patients in APO401 to Evaluate Adverse Events During Dose Introduction in Apomorphine-naïve Patients.

NCT00145171

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations: Not specified

View Trial Details

Completed

Long Term Safety and Efficacy of SC Apomorphine in Treatment of "Off" Episodes in Late-Stage Parkinson's Disease

NCT00142545

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations: Mylan Pharmaceuticals Morgantown, West Virginia, United States

View Trial Details

Completed

Continuously Infused Intracerebral (IC) Recombinant-Methionyl Human Glial Cell Line-Derived Neurotrophic Factor (r-metHuGDNF) for the Treatment of Idiopathic Parkinson's Disease

NCT00006488

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations: Department of Neurology New York, United States

View Trial Details

Completed

Phase II Double Blind Controlled Trial of Nigral Grafting in Patients With Parkinson's Disease

NCT00004387

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +13 more
Locations: Not specified

View Trial Details

Parkinsonian Disorders

Parkinsonian Disorders trial results

Related conditions